Fused-ring compounds and use thereof as drugs

Details Fused-ring compounds and use thereof as drugs Fused-ring compounds and use thereof as drugs

2006-09-26

2006-09-26

Wilson, James O. (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S305100, C548S304100, C548S253000, C548S181000, C514S234500, C514S381000, C514S254080, C514S378000, C514S338000, C514S365000

Reexamination Certificate

active

07112600

ABSTRACT:
The present invention provides a fused ring compound of the following formula [I] wherein each symbol is as defined in the specification, a pharmaceutically acceptable salt thereof, and a therapeutic agent for hepatitis C, which contains this compound. The compound of the present invention shows an anti-hepatitis C virus (HCV) action based on the HCV polymerase inhibitory activity, and is useful as a therapeutic agent or prophylactic agent for hepatitis C.

REFERENCES:
patent: 3644382 (1972-02-01), Clemence et al.
patent: 3778504 (1973-12-01), Clemence et al.
patent: 4250317 (1981-02-01), Meyer et al.
patent: 4360679 (1982-11-01), Meyer et al.
patent: 5280030 (1994-01-01), Jegham et al.
patent: 5563143 (1996-10-01), Cohan et al.
patent: 5633388 (1997-05-01), Diana et al.
patent: 5814651 (1998-09-01), Duplantier et al.
patent: 5998398 (1999-12-01), Daluge et al.
patent: 6166219 (2000-12-01), Yamasaki et al.
patent: 6211177 (2001-04-01), Sperl et al.
patent: 6448281 (2002-09-01), Beaulieu et al.
patent: 6770666 (2004-08-01), Hashimoto et al.
patent: 2003/0050320 (2003-03-01), Hashimoto et al.
patent: 2004/0082635 (2004-04-01), Hashimoto et al.
patent: 2004/0097438 (2004-05-01), Hashimoto et al.
patent: 0 010 063 (1980-04-01), None
patent: 0 507 650 (1992-10-01), None
patent: 0 694 535 (1996-01-01), None
patent: 03 031264 (1991-02-01), None
patent: 06-025182 (1994-02-01), None
patent: 06-025182 (1994-02-01), None
patent: WO 96/07646 (1996-03-01), None
patent: WO 96/35713 (1996-11-01), None
patent: WO 97/25316 (1997-07-01), None
patent: WO 97/41884 (1997-11-01), None
patent: WO 97/46237 (1997-12-01), None
patent: WO 98/05327 (1998-02-01), None
patent: WO 98/37072 (1998-08-01), None
patent: WO 98/50029 (1998-11-01), None
patent: WO 98/50030 (1998-11-01), None
patent: WO 98/50031 (1998-11-01), None
patent: WO 99/24060 (1999-05-01), None
patent: WO 99/51619 (1999-10-01), None
patent: WO 01/21634 (2001-03-01), None
patent: WO 01/47883 (2001-07-01), None
patent: WO 02/04425 (2002-01-01), None
U.S. Appl. No. 60/216,084, filed Jul. 6, 2000, Beaulieu.
Haskell et al., “Neuraminidase Inhibition and Viral Chemotherapy,”Journal of Medicinal Chemistry,13(4), 697-704 (1970).
Behrens et al., “Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus,”The EMBO Journal,15(1), 12-22 (1996).
Minami et al., “Skin Disorders in Hepatitis C Virus Antibody Positive Patients,”The Japanese Journal of Dermatology,111(7), 1075-1081 (2001).
Kataev et al., “Preparation and immunomodulating effect of (1-thietanyl-3)benzimidazoles,”Khimiko-Farmatsevticheskii Zhurnal,30(7), 22-24 (1996).
Khaliullin et al., “Synthesis of biologically active derivatives of xanthine and benzimidazole,”Chemical Abstracts Service,Columbus, Ohio, Database Accession No. 129:493337 (1997).
Orjales et al., “New 2-Piperazinylbenzimidazole Derivatives as 5-HT3Antagonists. Synthesis and Pharmacological Evaluation,”J. Med. Chem.,40(4), 586-593 (1997).
Kataev et al., “Synthesis and Immunostimulation Activity of 1-(Thietan-3-yl) Benzimidazoles,”Pharmaceutical Chemistry Journal,30(7), 448-450 (1996).
Hori et al., “Design and Syntheses of a Series of Novel Serotonin3Antagonists,”Chem. Pharm. Bull.,41 (10), 1832-1841 (1993).

Affiliated with

Also associated with

Rating

Fused-ring compounds and use thereof as drugs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fused-ring compounds and use thereof as drugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused-ring compounds and use thereof as drugs will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3539599